The Role of the Use of Low Molecular Weight Heparin in the Prevention of Deep Venous Thrombosis after Total Knee Arthroplasty

Background A prospective clinical study was performed to compare the efficacy of the use of lowmolecular- weight heparin group (enoxparin group) with control group in the prevention of deep-vein thrombosis after total knee arthroplasty. Aim of the study: to assess the prevalence of DVT after total...

Full description

Bibliographic Details
Main Authors: Auday H. Jasim, Abdullah Y. Khudiar
Format: Article
Language:English
Published: University of Baghdad/ Al-Kindy College of Medicine 2011-12-01
Series:مجله كليه طب الكندي
Subjects:
Online Access:https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/650
_version_ 1811275662277738496
author Auday H. Jasim
Abdullah Y. Khudiar
author_facet Auday H. Jasim
Abdullah Y. Khudiar
author_sort Auday H. Jasim
collection DOAJ
description Background A prospective clinical study was performed to compare the efficacy of the use of lowmolecular- weight heparin group (enoxparin group) with control group in the prevention of deep-vein thrombosis after total knee arthroplasty. Aim of the study: to assess the prevalence of DVT after total knee arthroplasty and evaluate the importance of the use of low molecular weight heparin in the prevention of this DVT. Methods Thirty-three patients undergoing total knee arthroplasty were randomly divided into two groups. One group consisted of 12 patients who received no prophylaxis with an anticoagulant (the control group), other group consisted of 21 patients who received the low-molecular-weight heparin enoxparin (enoxparin group) 4000 I.U. S.C 6 hours after surgery for two weeks after the operation then aspirin 100 mg until 6th week after operation. Bilateral duplex ultrasonography was performed preoperatively and at (5-7) days postoperatively. Results The prevalence of deep-vein thrombosis was 58% in the control group, 38% in the enoxparin group. Conclusions Enoxaparin significantly lowered the prevalence of deep-vein thrombosis after total knee arthroplasty.
first_indexed 2024-04-12T23:42:55Z
format Article
id doaj.art-b44cbc84736e43be850b5b99225cf8d4
institution Directory Open Access Journal
issn 1810-9543
2521-4365
language English
last_indexed 2024-04-12T23:42:55Z
publishDate 2011-12-01
publisher University of Baghdad/ Al-Kindy College of Medicine
record_format Article
series مجله كليه طب الكندي
spelling doaj.art-b44cbc84736e43be850b5b99225cf8d42022-12-22T03:11:57ZengUniversity of Baghdad/ Al-Kindy College of Medicineمجله كليه طب الكندي1810-95432521-43652011-12-0172The Role of the Use of Low Molecular Weight Heparin in the Prevention of Deep Venous Thrombosis after Total Knee ArthroplastyAuday H. Jasim0Abdullah Y. Khudiar1*From the Department of consultant Orthopaedic Surgeon*From the Department of consultant Orthopaedic Surgeon Background A prospective clinical study was performed to compare the efficacy of the use of lowmolecular- weight heparin group (enoxparin group) with control group in the prevention of deep-vein thrombosis after total knee arthroplasty. Aim of the study: to assess the prevalence of DVT after total knee arthroplasty and evaluate the importance of the use of low molecular weight heparin in the prevention of this DVT. Methods Thirty-three patients undergoing total knee arthroplasty were randomly divided into two groups. One group consisted of 12 patients who received no prophylaxis with an anticoagulant (the control group), other group consisted of 21 patients who received the low-molecular-weight heparin enoxparin (enoxparin group) 4000 I.U. S.C 6 hours after surgery for two weeks after the operation then aspirin 100 mg until 6th week after operation. Bilateral duplex ultrasonography was performed preoperatively and at (5-7) days postoperatively. Results The prevalence of deep-vein thrombosis was 58% in the control group, 38% in the enoxparin group. Conclusions Enoxaparin significantly lowered the prevalence of deep-vein thrombosis after total knee arthroplasty. https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/650(Deep-vein thrombosis,Enoxaparin,pulmonary embolism)
spellingShingle Auday H. Jasim
Abdullah Y. Khudiar
The Role of the Use of Low Molecular Weight Heparin in the Prevention of Deep Venous Thrombosis after Total Knee Arthroplasty
مجله كليه طب الكندي
(Deep-vein thrombosis,
Enoxaparin,
pulmonary embolism)
title The Role of the Use of Low Molecular Weight Heparin in the Prevention of Deep Venous Thrombosis after Total Knee Arthroplasty
title_full The Role of the Use of Low Molecular Weight Heparin in the Prevention of Deep Venous Thrombosis after Total Knee Arthroplasty
title_fullStr The Role of the Use of Low Molecular Weight Heparin in the Prevention of Deep Venous Thrombosis after Total Knee Arthroplasty
title_full_unstemmed The Role of the Use of Low Molecular Weight Heparin in the Prevention of Deep Venous Thrombosis after Total Knee Arthroplasty
title_short The Role of the Use of Low Molecular Weight Heparin in the Prevention of Deep Venous Thrombosis after Total Knee Arthroplasty
title_sort role of the use of low molecular weight heparin in the prevention of deep venous thrombosis after total knee arthroplasty
topic (Deep-vein thrombosis,
Enoxaparin,
pulmonary embolism)
url https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/650
work_keys_str_mv AT audayhjasim theroleoftheuseoflowmolecularweightheparininthepreventionofdeepvenousthrombosisaftertotalkneearthroplasty
AT abdullahykhudiar theroleoftheuseoflowmolecularweightheparininthepreventionofdeepvenousthrombosisaftertotalkneearthroplasty
AT audayhjasim roleoftheuseoflowmolecularweightheparininthepreventionofdeepvenousthrombosisaftertotalkneearthroplasty
AT abdullahykhudiar roleoftheuseoflowmolecularweightheparininthepreventionofdeepvenousthrombosisaftertotalkneearthroplasty